7THO
Integrin alpha IIB beta3 complex with Eptifibatide
7THO の概要
| エントリーDOI | 10.2210/pdb7tho/pdb |
| 関連するPDBエントリー | 7TCT 7TD8 |
| 関連するBIRD辞書のPRD_ID | PRD_002490 |
| 分子名称 | Integrin alpha-IIb, SULFATE ION, MAGNESIUM ION, ... (13 entities in total) |
| 機能のキーワード | complex, inhibitor, blood clotting, blood clotting-inhibitor complex, blood clotting/inhibitor |
| 由来する生物種 | Homo sapiens (human) 詳細 |
| タンパク質・核酸の鎖数 | 10 |
| 化学式量合計 | 300924.51 |
| 構造登録者 | |
| 主引用文献 | Lin, F.Y.,Li, J.,Xie, Y.,Zhu, J.,Huong Nguyen, T.T.,Zhang, Y.,Zhu, J.,Springer, T.A. A general chemical principle for creating closure-stabilizing integrin inhibitors. Cell, 185:3533-3550.e27, 2022 Cited by PubMed Abstract: Integrins are validated drug targets with six approved therapeutics. However, small-molecule inhibitors to three integrins failed in late-stage clinical trials for chronic indications. Such unfavorable outcomes may in part be caused by partial agonism, i.e., the stabilization of the high-affinity, extended-open integrin conformation. Here, we show that the failed, small-molecule inhibitors of integrins αIIbβ3 and α4β1 stabilize the high-affinity conformation. Furthermore, we discovered a simple chemical feature present in multiple αIIbβ3 antagonists that stabilizes integrins in their bent-closed conformation. Closing inhibitors contain a polar nitrogen atom that stabilizes, via hydrogen bonds, a water molecule that intervenes between a serine residue and the metal in the metal-ion-dependent adhesion site (MIDAS). Expulsion of this water is a requisite for transition to the open conformation. This change in metal coordination is general to integrins, suggesting broad applicability of the drug-design principle to the integrin family, as validated with a distantly related integrin, α4β1. PubMed: 36113427DOI: 10.1016/j.cell.2022.08.008 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (2.75 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






